With our successful advancement of two new major technologies, both highly disruptive and each changing the face of technology, BCM Industries (BCM) has emerged as a super-hot startup. First is the forthcoming arrival of the Tissue Operating Device (TOD™), which performs tissue computing with live neural network processing. Tissue Computing can perform complex and larger processing tasks 1,000 times faster than a standard digital computer. Tissue processing technology will soon impact everyone and everything. The second is Autologous Regenerative Tissue Replacement (ARTR™), which provides regenerative cell repair for human livers, lungs, kidneys, and pancreas. This disruptive technology can eliminate the need for organ transplants. It is also being expanded to address regenerative tissue repair of mussels, joints, and bones. To learn more, review this BCM Industries website.